LU86044A1 - Nouvelles preparations pharmaceutiques - Google Patents

Nouvelles preparations pharmaceutiques Download PDF

Info

Publication number
LU86044A1
LU86044A1 LU86044A LU86044A LU86044A1 LU 86044 A1 LU86044 A1 LU 86044A1 LU 86044 A LU86044 A LU 86044A LU 86044 A LU86044 A LU 86044A LU 86044 A1 LU86044 A1 LU 86044A1
Authority
LU
Luxembourg
Prior art keywords
theophylline
pharmaceutical preparation
approximately
microgranules
preparation according
Prior art date
Application number
LU86044A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU86044A1 publication Critical patent/LU86044A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU86044A 1984-08-16 1985-08-16 Nouvelles preparations pharmaceutiques LU86044A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH392784 1984-08-16
CH392784 1984-08-16
CH438784 1984-09-14
CH438784 1984-09-14

Publications (1)

Publication Number Publication Date
LU86044A1 true LU86044A1 (fr) 1986-02-18

Family

ID=25694194

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86044A LU86044A1 (fr) 1984-08-16 1985-08-16 Nouvelles preparations pharmaceutiques

Country Status (15)

Country Link
AU (1) AU4617185A (de)
BE (1) BE903065A (de)
DE (1) DE3528481A1 (de)
DK (1) DK370085A (de)
FR (1) FR2569109A1 (de)
GB (1) GB2163957A (de)
GR (1) GR851988B (de)
HU (1) HUT40568A (de)
IL (1) IL76089A0 (de)
IT (1) IT1200102B (de)
LU (1) LU86044A1 (de)
NL (1) NL8502178A (de)
PT (1) PT80961B (de)
SE (1) SE8503771L (de)
WO (1) WO1986001108A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
AR036797A1 (es) 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
US20060083714A1 (en) * 2003-01-27 2006-04-20 Warner James M Combination of a pde iv inhibitor and a tnf-alpha antagonist
WO2004093883A2 (en) 2003-04-23 2004-11-04 Ferring B.V. Sachet for a pharmaceutical composition
EP1547601A1 (de) 2003-12-23 2005-06-29 Ferring B.V. Beschichtungsverfahren
CN106913572B (zh) * 2017-04-06 2019-09-20 地奥集团成都药业股份有限公司 一种复方茶酮缓释片及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51142543A (en) * 1975-05-20 1976-12-08 Sandoz Ag Improvement in organic compound

Also Published As

Publication number Publication date
SE8503771L (sv) 1986-02-17
GB2163957A (en) 1986-03-12
GR851988B (de) 1985-12-10
HUT40568A (en) 1987-01-28
WO1986001108A1 (fr) 1986-02-27
NL8502178A (nl) 1986-03-17
IT8548441A0 (it) 1985-08-02
PT80961B (en) 1987-07-13
DK370085D0 (da) 1985-08-14
BE903065A (fr) 1986-02-14
DE3528481A1 (de) 1986-02-27
AU4617185A (en) 1986-02-20
PT80961A (en) 1985-09-01
IL76089A0 (en) 1985-12-31
SE8503771D0 (sv) 1985-08-12
IT1200102B (it) 1989-01-05
DK370085A (da) 1986-02-17
FR2569109A1 (fr) 1986-02-21
GB8520189D0 (en) 1985-09-18

Similar Documents

Publication Publication Date Title
BE1013726A5 (fr) Procede de traitement de troubles metaboliques, en particulier du diabete, ou d'une maladie ou d'une affection associee au diabete.
CA2618212C (fr) Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte et son application therapeutique
JP5091106B2 (ja) 真性糖尿病の治療のためのロフルミラスト
EP1389118B9 (de) Oral anzuwendende zuckerkrankheitshemmende "einmal täglich" arzneizusammensetzung enthaltend eine biguanidverbindung und zumindestens einen anderen wirkstoff
BE1011925A3 (fr) Pilules de fluoxetine enteriques.
EP2018158B1 (de) Neue form der verabreichung von racecadotril
JP2001503737A (ja) 糖尿病の発生を防止するためのシブトラミン類似体の利用
WO2006047248A1 (en) Combination of dpp-iv inhibitor, ppar antidiabetic and metformin
US11291658B2 (en) Use of gaboxadol in the treatment of diabetes and related conditions
LU86044A1 (fr) Nouvelles preparations pharmaceutiques
JPWO2007007757A1 (ja) ＰＰＡＲγアゴニストを含有する医薬組成物
JPH01186883A (ja) 抗アテローム性動脈硬化症剤としてのｄｌ‐５‐〔（２ベンジル‐３，４‐ジヒドロ‐２Ｈ‐ベンゾピラン‐６‐イル）メチル〕チアゾリジン‐２，４‐ジオン
FR2587213A1 (fr) Medicament pour le traitement de la dependance aux psychostimulants
CA2400886C (fr) Nouvelle forme galenique orale a liberation prolongee de la molsidomine
WO2002041897A2 (fr) Compositions pharmaceutiques a action antidiabetique constitues de l'association d'un biguanide et d'un sulfonamide
ITMI20002019A1 (it) Metodo per il trattemento dei disturbi metabolici, in particolare diabete oppure una malattia oppure una condizione associate con il diabete
JPWO2007037296A1 (ja) インスリン抵抗性改善剤を含有する薬剤
JPS6157516A (ja) 新規医薬製剤